Obesity

Adults with obesity who have been prescribed tirzepatide can now purchase 2.5 mg and 5 mg single-dose vials of the medication, Eli Lilly announced.

Adults who take semaglutide may have increased risk for developing suicidal thoughts, according to results from a case-control study published in JAMA Network Open.

A majority of people with diabetes rely on their primary care provider for diabetes management and believe using drugs such as GLP-1 receptor agonists are enough to manage their disease, according to survey results.

A novel prognostic model identified risk factors including smoking, obesity, HbA1c and albuminuria as significant predictors of incident heart failure risk among Native American adults, researchers reported.

Adults with prediabetes and overweight or obesity have a 94% lower risk for developing type 2 diabetes with the once-weekly GIP/GLP-1 dual agonist tirzepatide vs. placebo, according to top-line results from the SURMOUNT-1 3-year study.

Twelve circulating proteins associated with obesity and heart failure may inform treatment for adults with both conditions, according to a study published in Obesity.

Women with vs. without intellectual and developmental disabilities have greater risks for stillbirth and other adverse obstetric, mental health and medical outcomes, according to findings published in JAMA Network Open.

Researchers purchased prefilled semaglutide pens from six online vendors, of which three were nondelivery scams, according to findings from a research letter published in JAMA Network Open.

An analysis of patients with head and neck squamous cell carcinoma who received immune checkpoint inhibitors showed those with obesity survived longer than those with normal BMI.

Ambient air pollution was associated with an increased risk for adverse events among Medicare beneficiaries with preexisting HF, according to a study published in the Journal of the American Heart Association.